Browse Category

Stock Market News News 16 October 2025 - 31 October 2025

Quantum Rocket or Bubble? RGTI’s Stunning Surge Explained—And How It Stacks Up to IonQ, D‑Wave, and QUBT

Rigetti (RGTI) Quantum Stock Skyrockets 5,000% – October 2025 News, Price & Analyst Report

Key Facts: Rigetti Computing (NASDAQ: RGTI) has been on a historic tear in 2025, rising roughly 50× from penny-stock levels to intraday highs near $56ts2.tech. By Oct. 30, 2025 it closed around $42.52 (up 7.9% on the day)stockanalysis.com. Its YTD gain (~2,800–5,000%) far eclipses peers like IonQ (+270%) or D-Wave (up thousands of %)ts2.tech. Recent catalysts include major deals and tech wins: in late Sept 2025 Rigetti (with Dutch partner QphoX) won a $5.8 M U.S. Air Force quantum-networking contract and concurrently booked ~$5.7 M in orders for two new 9-qubit Novera™ systemsts2.techrigetti.com. In late Oct, Rigetti announced support for NVIDIA’s NVQLink
Bristol Myers Squibb (NYSE:BMY) Surges on Q3 Earnings Beat and Raised Outlook – What’s Next for BMY Stock?

Bristol Myers Squibb (NYSE:BMY) Surges on Q3 Earnings Beat and Raised Outlook – What’s Next for BMY Stock?

BMY Stock Bounces After Earnings – Recent Performance Bristol Myers Squibb’s stock has been under pressure for most of 2025, but the Q3 report provided a much-needed boost. Heading into earnings, BMY shares were near 52-week lows, reflecting investor skittishness over looming patent cliffs and mixed news in prior quarters. In fact, on October 28, the stock touched a one-year low of $42.96 (closing at $42.99) Marketbeat. That put BMY down roughly 18–19% year-to-date, significantly underperforming the pharma sector (which was roughly flat to slightly up over the same period) Nasdaq. By comparison, an index of large pharmaceutical stocks was
Skyworks Soars 18% on $22B Qorvo Merger – What’s Next for the Chipmaker?

Skyworks Soars 18% on $22B Qorvo Merger – What’s Next for the Chipmaker?

Skyworks’ stock surge on Oct. 28 was driven almost entirely by the surprise merger announcement. In pre-market trading, shares spiked ~12% reuters.com, and by 9:48 a.m. ET the stock was around $89.22 (from about $75.84 Monday’s close) investing.com investing.com. This massive gap up reflects investor excitement: combined, Skyworks and Qorvo would control roughly $7.7 billion in annual RF-chip revenue (≈$5.1B mobile + $2.6B broadband) stocktitan.net, making a top U.S. analog/5G semiconductor supplier. The market welcomed the logic that scale and cross-selling should boost earnings – for example StockTitan notes the deal is “immediately accretive” to EPS and targets >$500M in yearly cost
Fluence Energy Stock Skyrockets on Battery Boom – Is the FLNC Rally Here to Stay?

Fluence Energy (FLNC) Stock Skyrockets on $10B Battery Boost and AI Demand – Analysts Sound Warning

Stock Performance & Recent Volatility Fluence’s share price has been on a roller-coaster. After languishing around the mid-$5 range in early September, FLNC surged over 80% to the high teens by mid-Octoberts2.tech. For example, on Oct 13 the stock jumped ~21% to about $15.89, and on Oct 14 it gained another ~16% to ~$18.45ts2.tech. In mid-October the shares briefly hit roughly a 52-week high near $24.00 (the past 12-month range is about $3.46–$24.00)marketbeat.com. On Oct 25, Fluence closed at $19.52, up +21.8% on the dayreuters.com, continuing a week-long rally. These swings illustrate extreme volatility: FLNC has moved by double digits
Integer Holdings (NYSE: ITGR) Stock Plunges 37% on Revised Forecast – Key Takeaways

Integer Holdings (NYSE: ITGR) Stock Plunges 37% on Revised Forecast – Key Takeaways

Stock Dives on Oct. 23, 2025 Integer’s stock slumped sharply on Oct. 23 after investors digested the latest financial news. According to Reuters, ITGR was trading around $68.67 (down about 37%) as of mid-dayreuters.com – one of its worst single-day drops on recordtradingview.com. For context, the stock had opened near $85 on Oct. 23 against a prior close around $109reuters.com. This dramatic fall came despite a largely solid earnings report, reflecting concerns over the company’s revised outlook and upcoming market challenges. The share plunge outpaced the overall market’s modest gains. Investors noted that Integer had narrowed its revenue guidance for
Archer Aviation Skyrockets: eVTOL Test Milestones & Stock Surge Ignite Industry Buzz

Archer Aviation (ACHR) Soars on Korean Air Deal – eVTOL Stock Skyrockets Amid Air Taxi Race

Korean Air Deal Lifts ACHR Stock Archer Aviation made headlines on Oct. 20 by inking a partnership with Korean Air to commercialize its Midnight eVTOL air taxi in South Koreareuters.com. The deal includes a potential order for up to 100 Midnight aircraft, marking Archer’s first major airline customer in Asia. News of the “landmark partnership” sent ACHR shares up about 4–6% in early trading that dayreuters.comtokenist.com, as investors cheered the validation by a global flag-carrier. Korean Air – with five decades of aerospace experience – will help Archer deploy Midnight across multiple use cases, starting with government and emergency applications
Zions Bancorp Stock Plunges 13% After Surprise $50M Fraud-Linked Loan Loss – Is More Trouble Ahead?

Zions Bancorp Stock Plunges 13% After Surprise $50M Fraud-Linked Loan Loss – Is More Trouble Ahead?

Fraudulent Loan Bombshell Hits Zions’ Books Zions Bancorporation shocked the market this week by revealing a significant credit mishap at its California division. In a late Wednesday 8-K filing, the Salt Lake City-based regional bank disclosed it discovered potential fraud in two related commercial loans totaling about $60 million Investing. After an internal review unearthed “misrepresentations and irregularities” by the borrowers, Zions decided to write off $50 million of the loans and take a provision for the rest, effectively recognizing a total $60 million exposure as likely lost Investing. The bank has already accelerated the loans to default and filed
Recursion (RXRX) Stock Surges on AI-Driven Breakthroughs and Big-Pharma Deals

Recursion (RXRX) Stock Surges on AI-Driven Breakthroughs and Big-Pharma Deals

Recursion Pharmaceuticals (NASDAQ: RXRX) is a Salt Lake City–based clinical-stage “TechBio” biotech that uses AI, automation and massive biological datasets to speed drug discoveryts2.tech. In early October 2025 the stock showed wild swings: it plunged to the mid-$5s then rebounded ~16% on Oct 8 after an AI-focused tech conference and pipeline newsts2.techts2.tech. As of mid-day Oct 16, RXRX trades around $6.5, having closed at ~$6.79 on Oct 16insidermonkey.com. This volatility reflects renewed investor interest in Recursion’s AI platform and upcoming trial readouts. Key Facts Recent Stock Performance Recursion’s share price has been unusually volatile in October 2025. On Oct 7
Kelly Services’ Tech-Driven Hiring Triumphs Spark Stock Rally Hopes

Kelly Services’ Tech-Driven Hiring Triumphs Spark Stock Rally Hopes

Double Honors in Staffing Leadership Kelly Services has grabbed headlines by earning dual top honors from leading industry analyst Everest Group. In the newly released 2025 U.S. Contingent Staffing PEAK Matrix assessments, Kelly was designated both a Leader and a Star Performer, recognizing its superior capabilities and momentum in supplying talent. Notably, Kelly achieved this in both the professional/administrative and industrial staffing categories, marking “the first time any firm” has ever swept both distinctions across all evaluated segments ts2.tech. This unprecedented feat underscores how far the 77-year-old staffing giant has evolved beyond traditional temp services into a tech-savvy talent solutions
16 October 2025
Travelers Companies (TRV) Q3 Earnings Blow Past Estimates as Catastrophe Losses Tumble – Analysts Weigh In

Travelers Companies (TRV) Q3 Earnings Blow Past Estimates as Catastrophe Losses Tumble – Analysts Weigh In

Stellar Q3 Lifts Earnings – Stock Reaction Travelers’ Q3 earnings report (released Oct. 16 before markets) showed robust profitability and low catastrophe losses. Core income jumped to $8.14 per diluted sharereuters.com, crushing prior-year ($5.24) and analyst forecastsbenzinga.com. Net income was ~$1.888B (≈$8.24/sh), up ~52% from 2024, on revenues of $12.47B (above forecasts)tokenist.com. Underwriting gains more than doubled year-over-year, helped by a swing in catastrophe costs (only $402M vs $939M prior year)reuters.comgurufocus.com. The combined ratio (losses plus expenses / premiums) was a very strong 87–84% rangereuters.comgurufocus.com. Early trading on Oct. 16 saw the stock pull back (MarketBeat reported TRV ~$257.74 in
Sonder Holdings (SOND) Stock Skyrockets 50% After Q2 Earnings and New Partnership Surprise

Sonder Holdings (SOND) Stock Skyrockets 50% After Q2 Earnings and New Partnership Surprise

Stock Rebound After Hitting Record Lows Sonder’s stock price is on a rollercoaster this week. On Wednesday, Oct. 15, SOND closed at $0.92, down nearly 4% for the day and extending a multi-day slump marketbeat.com. In fact, shares had crumbled about 20% just in the past week and nearly 45% over the past month marketscreener.com, touching historic lows around $0.95. This precipitous decline has wiped out 75% of Sonder’s market value in the last year finviz.com, and astonishingly, the stock now sits 97% below its levels of three years ago finviz.com (when the company went public via SPAC in 2021).
Uranium Royalty Stock Soars on Nuclear Boom – UROY Hits New High, What’s Next?

Uranium Royalty Stock Soars on Nuclear Boom – UROY Hits New High, What’s Next?

UROY Stock Blasts Off Amid Uranium Market Revival Uranium Royalty Corp’s stock price has been on a tear, riding a wave of optimism in the nuclear energy sector. On October 15, UROY spiked intraday to about $4.87 per share, its highest level in a year Marketbeat. It closed that session up over 11% at roughly $4.75 Finviz – capping a stunning rally in recent months. Just a year ago UROY traded near $2.50; it has since doubled in value, now sitting ~85% higher than 12 months prior Finviz. Over 116% of those gains have come in 2025 alone as the

Stock Market Today

South32 share price drops 4% in ASX rout — what investors watch before results

South32 share price drops 4% in ASX rout — what investors watch before results

7 February 2026
South32 shares fell 4.1% to A$4.41 Friday as Australian miners dropped in the worst ASX session since April 2025. The S&P/ASX 200 lost 2%, erasing almost A$70 billion in value. South32’s half-year results and interim dividend decision are set for Feb. 12. Markets reopen Monday with investors watching for further volatility.
Wesfarmers share price: what to watch on ASX next week as results loom

Wesfarmers share price: what to watch on ASX next week as results loom

7 February 2026
Wesfarmers shares closed down 1.33% at A$85.04 on Friday, following a sharp drop in the S&P/ASX 200, which fell 2% for its steepest one-day loss in 10 months. Investors are watching for Australia’s household spending data next week and Wesfarmers’ half-year results due Feb. 19.
Go toTop